Apoptosis is likely to be the main form of beta-cell death in immune-mediated diabetes mellitus in rodents and possibly in humans. Clarification of the regulation of beta-cell death could indicate novel sites for therapeutic intervention in Type I (insulindependent) diabetes mellitus. We review the molecular effectors and signal transduction of immune-mediated beta-cell apoptosis.
The term apoptosis, or programmed cell death, is used to describe the regulated disposal of a cell. Following signals delivered by cell surface ligands, viral infection, cytokines, absence of supporting growth factors etc, the target cells shrink and go through a process which includes chromatin condensation, protein cleavage, DNA degradation, fragmentation into membrane-bound apoptotic bodies and phagocytosis by neighbouring cells, with little or no inflammatory response. Apoptotic cell death contrasts with necrotic, or accidental cell death, which is usually triggered by acute loss of cell homeostasis. Necrosis leads to cellular swelling, early plasma membrane rupture and disruption of cellular organelles. The resulting leakage of intracellular contents causes local inflammatory response. The morphology of beta cell apoptosis and necrosis has been previously reviewed [1] .
Recent evidence points to apoptosis as the main form of beta-cell death in animal models of Type I (insulin dependent) diabetes mellitus [2] . This raised the possibility that human beta cells also die by apoptosis in early Type I diabetes which has instigated more than 200 studies addressing beta-cell apoptosis since 1993. But, why bother with the mode by which beta-cells are killed? They will be gone anyway and the patients will become insulin-dependent for life, independently from the fact that his/her beta-cells died by apoptosis or necrosis. The main reasons for the increasing interest in this field are that: firstly, identification of the form of cell death in Type I diabetes could provide valuable clues for the cause of cell death; and secondly, apoptosis can be arrested at early checkpoints, often allowing preservation of cell function [3] . Thus, elucidation of the process of betacell death and of the cell-death machinery in these cells, could disclose multiple sites for therapeutic intervention in Type I diabetes.
Recent reviews have addressed different aspects of beta-cell apoptosis, both in Type I and Type II (non-insulin-dependent) diabetes mellitus, and during development [1, 2, 4±8] . We focus on the molecular effectors and signal-transduction of immune-mediated beta-cell apoptosis, with special emphasis on recent developments in the field.
Beta-cell apoptosis in experimental and clinical Type I diabetes mellitus
Apoptosis is mostly asynchronous. The cells undergoing apoptosis show a number of ªeat-meº flags, such as modifications in surface sugars or exposure of inner-membrane phosphatidylserines, leading to early phagocytosis by neighbouring cells or by professional scavengers of the macrophage line [9, 10] . For instance, the clearance of apoptotic beta cells in NOD mice has been estimated to be executed in the range of 1.7 [11] to 11 min [12] . These characteristics make it very difficult to detect apoptotic cells in vivo in NOD mice or BB rats, two animal models of Type I diabetes where the process of beta-cell destruction takes days to weeks and makes it nearly impossible to detect apoptotic cells in the pancreata of Type I diabetes patients in whom beta-cell destruction could proceed for several months or years.
Despite these difficulties, beta-cell apoptosis has been shown in both spontaneous [12, 13] and accelerated [11, 14, 15] diabetes in NOD mice, detected by the deoxynucleotide transferase (TdT)-mediated dUTP nick-end labelling (TUNEL) method. Betacell apoptosis was also observed in the multiple lowdose streptozotocin model in mice (an animal model where diabetes is triggered by both toxic and immune components) [16] and in transgenic mice expressing interferon-g (IFNg), under the control of the rat glucagon promoter [17] . In the latter model, beta-cell apoptosis was compensated by vigorous regeneration, and most animals did not develop hyperglycaemia [17] . A large proportion of apoptotic cells in and around the islets are infiltrating T cells [12, 14] , which emphasizes the need to carefully identify the cells undergoing cell death by double-staining with insulin.
Of note, beta-cell apoptosis is present in diabetesprone NOD mice prior to light-microscopically evident T-cell infiltration [13] , suggesting that initial beta-cell death in this model is triggered by a few infiltrating T-cells and/or soluble mediators released by macrophages, the first cells to infiltrate the islets [18] . The time course of beta-cell apoptosis was further investigated by a study with serial biopsies carried out in diabetes prone and diabetes resistant BB rats [19] . Islet cell apoptosis was initially detected at 68 days of age in the diabetes prone and diabetes resistant BB rats, correlating with early insulitis and a decrease in pancreatic insulin staining. A further increase in islet apoptosis was present in the diabetes prone, but not in the diabetes resistant BB rats, at 85 days, coinciding with the onset of diabetes [19] . Although the authors showed histological evidence that some of the cells undergoing apoptosis were insulin positive, there was no double-staining for insulin in the preparations used to determine the number of apoptotic cells in islets. It is thus not clear if the majority of cells undergoing apoptosis are indeed beta-cells.
The observations described above suggest that apoptosis is the main, but probably not the only, form of beta-cell death in animal models of autoimmune diabetes; necrosis could also be involved. Much less information is available regarding human Type I diabetes. Thus, whereas one study claimed that apoptosis was observed in beta-cells from two young patients who died in ketoacidosis after diagnosis of Type I diabetes [20] , this was not confirmed in a subsequent study of pancreas biopsy specimens from 13 recentonset diabetic patients [21] . Both studies showed evi-dence of Fas expression in the beta-cells, while FasL was present on infiltrating mononuclear cells [20, 21] . In other words, while both studies showed evidence of the presence of the ªmurder weaponº, only one of them was able to present the corpse. This is not surprising, taking into account the difficulties in identifying apoptotic cells in the course of a long-lasting autoimmune assault.
The in vivo effectors of beta-cell apoptosis
The immune system utilizes various mechanisms to eliminate target cells for host defence against infectious agents and malignant transformation, but also as part of autoimmune disease. It is widely accepted that macrophages and T-cells are important effector cells leading to beta-cell destruction, whereas betacell autoreactive antibodies play a minor if any function [18] . Macrophages can induce target cell apoptosis via the synthesis of proinflammatory cytokines, such as IL-1 and TNFa, as well as nitric oxide and other free radicals. Activated T-cells produce apoptosis-inducing cytokines such as TNFa, lymphotoxin and IFNg. T-cells also express the ligand of the Fas receptor (Fas ligand ± FasL) and the tumour necrosis factor related apoptosis inducing ligand (TRAIL), both leading to apoptosis via activation of effector caspases. In addition, CD8 + cytotoxic T-cells have cytolytic granules containing perforin, which are released after the T-cell receptor is triggered. Perforin polymers are inserted into the target cell membrane as tubular pore complexes, allowing access of granzyme, another constituent of the cytotoxic T-cell granules, to the cytosol of the target cell. Granzyme is a protease that, upon cellular entry via the tubular pore complexes, activates nucleases and caspases leading to cell death [22] .
We review recent evidence obtained mostly in NOD mice regarding the relative importance of CD4 + and CD8 + T-cells as effector cells, and the putative role of Fas, the perforin-granzyme system and proinflammatory cytokines as mediators of beta-cell apoptosis. There is only limited information from studies on human Type I diabetes addressing these questions and caution should be exerted when extrapolating the reviewed animal-model data to the disease in humans.
Effector cells. It is unquestionable that T-cells are necessary for beta-cell destruction in animal models of Type I diabetes, but the relative role of the CD4 and CD8 T-cell subsets and the precise mechanisms by which these T-cells exert their effector function is not clear [23] In summary, macrophages are required and activated CD4 + T-cell are both necessary and sufficient in causing the disease, whereas CD8 + T-cell clones are necessary but usually not sufficient to cause beta-cell destruction. Only after appropriate co-stimulation or in unique transgenic T-cell receptors [27, 42] , are CD8 + T-cells sufficient in causing Type I diabetes. The precise mechanisms by which CD8 + T-cells provide the initiating signal to the CD4 + T-cells are currently not known.
The role of the perforin/granzyme system as effector mechanism. The available findings on the perforingranzyme effector system are somewhat contradictory and often dependent on the experimental model utilized. Naive beta-cells are resistant to cytolytic Tcell-mediated perforin-dependent killing in vitro, but they become sensitive after cytokine-induced upregulation of MHC Class I molecules [43] . It is questionable whether CD4 + T-cells can kill beta-cells by the perforin system, as this mechanism is dependent on MHC Class II recognition of the target cell and beta cells probably do not express MHC Class II. Accordingly, beta-cell killing by CD4 + and CD8 + T-cells expressing the diabetogenic 4.1 or 8.3 T-cell receptor clonotypes respectively is perforin-independent [44, 45] .
The available in vivo data on perforin are highly model-dependent. Thus, both in transgenic mice expressing the Lymphocytic Choriomeningitis virus glycoprotein under the control of the rat insulin promoter (RIP) and in the 8.3 T-cell receptor CD8 + T-cell mediated diabetes, beta-cell death is perforin-independent [44, 46, 47] . In contrast, CD8 + killing of beta cells in transgenic mice expressing the Influenza virus hemagglutinin under the RIP is dependent on perforin [48] . Furthermore, in double transgenic mice expressing TNF-a and the T-cell costimulatory molecule B7±1 under the control of the RIP, the development of diabetes is independent of perforin and Fas [49] . In a less artificial model, however, perforin deficient NOD mice have reduced incidence and delayed onset of Type I diabetes [50] .
This evidence suggests that beta-cell killing in NOD diabetes is partially dependent on perforin-mediated beta-cell killing by CD8 + T-cells. It remains to be established whether the putative initiating role of CD8 + T-cells also involves perforin as an effector mechanism. been highly contentious. In contrast, anti-cytokine intervention using antibodies or soluble receptors against IL-1, IL-6, TNFa and IFNg have almost unanimously shown inhibitory effects on diabetes in NOD mice and BB rats [18] . In recent years, transgenic techniques have been used in an attempt to clarify the role of locally produced cytokines in beta-cell destruction. We list experiments [17, 63±70] where cytokine transgenes have been introduced into beta cells of non-diabetes-prone animals ( Table 2 ). Only mice with IFN-a/g or TNF/B7-transgenic expression developed both insulitis and diabetes. It could be argued, however, that these studies are hampered by the fact that the transgene is introduced into animals not genetically predisposed to develop diabetes. We list the evidence where cytokine transgenes have been introduced into beta cells of NOD mice (Table 3) [71±77]. Betacell IL-2 expression accelerated NOD diabetes, probably by stimulating CD4 + T-cells [74] . In NOD mice with transgenic expression of TNFa in beta cells, the incidence of diabetes was either increased or decreased depending on the age of the animals at which the transgene was activated. This emphasizes that inflammatory mediators could have very diverse effects depending on the location of action and time-and concentration-windows.
Transgenic mice expressing IFN-g under the control of RIP have severe insulitis and destruction of pancreatic beta cells [64, 78, 79] . Treatment with anti-IFN-g prevents diabetes in IFN-g transgenic [80] mice. It is not clear whether these effects of IFN-g are due to: firstly, induction of MHC class I and II expression in infiltrated islets, enhancing CTL-mediated beta-cell damage; secondly, local or systemic effects on the immune system; thirdly, direct cytotoxic effects of the beta cells; and fourthly, any combinations of these effects. Transgenic NOD mice expressing a dominant negative mutant-IFN-g receptor in beta cells develop diabetes similarly to wild type animals [79] , and islets from IFN-g receptor KO are destroyed after allograft transplantation [81] , suggesting that IFN-g alone plays a minor direct role in beta-cell damage. However, beta-cell destruction in virus-induced diabetes requires effects of IFN-g on the beta cell [43] . Thus, it seems that the role of IFN-g for immune-mediated beta-cell death varies depending on the animal models utilized.
Diabetes in the RIP-TNFa/B7±1 model is mainly caused by co-stimulation of CD8 + T-cells and thereby breakdown of tolerance [73] but the relevance of this model is not clear, because beta cells are not known to express B7±1. IL-10 beta cell transgenics seem to have an increased incidence of diabetes via chemokine, especially ICAM-dependent, potentiation of islet inflammation [70] .
Overexpression studies can be criticized for eliciting numerous secondary effects and therefore several investigators have attempted to create systemically cytokine-deficient NOD mice (Table 4) [43, 46, 82±87]. Of note, NOD mice deficient in the signalling beta-chain of the IFN receptor were not protected against diabetes development [84] , whereas disruption of the ligand-binding a-chain of the IFN-g receptor was protective [83] . This protective effect is given by a closely located hitherto unidentified diabetes resistance allele [88] .
The ability of responding to IL-4, tested either by introducing IL-4 null mutation into NOD mice carrying rearranged T-cell receptor genes from a diabetogenic T-cell clone or by targeted mutation of the IL-4 receptor a-gene in the RIP Influenza virus haemagglutinin model, led to different results (Table 4 ). An explanation for this contradiction has not been found but it has been suggested that IL-4 is not exclusively a ªprotectiveº cytokine since IL-4 can trigger autoim- mune diabetes by increasing self-antigen presentation by dendritic cells within the pancreatic islets [89] . Clear conclusions are difficult to draw from the above cited studies. It should be kept in mind that the outcome of cytokine transgenic models is highly dependent upon whether local or systemic expression or knock-out is used and whether life-long versus time-defined expression or knock-out is obtained. Redundancy, compensatory mechanisms and secondary pathology must be considered [90] . Thus, single cytokine transgenic studies may only give limited information on the in vivo relevance of the local role of cytokines as effectors of beta-cell destruction. Furthermore, neither IL-1 nor cytokine combination overexpression and/or knock-out studies have been reported.
The studies reviewed above suggest that CD8 + Tcells participate in initiating the beta-cell destructive process via perforin-dependent or Fas-dependent mechanisms. In the later effector phase, a combination of beta-cell killing mediated by inflammatory cytokines and CD4 + cells, probably via the Fas/FasL system or by membrane bound TNF/TRAIL is involved [49, 60, 62].
The signal transduction of beta-cell death ± in vitro studies
Cytokine-induced beta-cell death. Following the original description of the inhibitory effects of IL-1 on rat islet function [91] , several studies have shown that this cytokine, alone or in combination with IFN-g and TNF-a leads to islet-cell dysfunction and death [18, 92] . Exposure of fluorescence activated cell sorting (FACS)-purified rat and mouse beta cells to interleukin-1b (IL-1b), in combination with IFN-g and/or TNF-a, leads to cell death by necrosis and predominantly by apoptosis [93±97]. Of note, the full proapoptotic effect of cytokines in rat beta cells is already achieved at relatively low concentrations of cytokines (10 U/ml IL-1b + 100 U/ml IFN-g) and higher concentrations of IL-1b + IFN-g fail to further increase the number of apoptotic cells (Fig. 1) . Similar results were observed with the necrosis index, which reached a significant increase compared to control beta cells already at IL-1b 10 U/ml + IFN-g 100 U/ml (33 5) and did not increase further when the higher cytokine concentrations were tested (data not shown). This suggests that primary beta cells have a limited number of cytokine receptors and do not further increase beta cell death once these are occupied by higher cytokine concentrations. The necrotic component of beta-cell death is probably related to nitric oxide production, because it is abolished in mice genetically inducible nitric oxide synthase deficient (iNOS ±/± or iNOS KO), whereas cytokine-induced apoptosis is delayed but not prevented [95, 98] .
When whole rat islets were exposed to IL-1b + IFNg + TNF-a there was a significant increase predominantly in necrosis (17 % dead cells after 24 h), whereas apoptosis was increased to a lesser extent (5 % dead cells after 24 h; [99] ). Both forms of cell death were abolished by concomitant exposure to an iNOS blocker [99] , which also prevented cytokine-induced DNA loss in NMRI islets [100] . Whole islets isolated from iNOS ±/± mice are much more resistant to IL1b + IFN-g + TNF-a-induced cell death than wild type (wt) islet cells (93 % dead cells in the wt group vs 28 % dead cells in the iNOS ±/± mice after 9 days exposure to cytokines) [95] . These findings suggest that iNOS-mediated nitric oxide formation is more important for cytokine-induced cell death in whole rodent islets than in purified beta cells. This could be due to the disappearance of intercellular capillary spaces in whole islets kept in culture for more than 48 h, leading to central ischaemia and allowing local accumulation of high amounts of nitric oxide [96] . However, it cannot be excluded that beta-cell FACS-purification, and the consequent loss of cellular contacts, modify the susceptibility of these cells to apoptosis.
Experiments with human pancreatic islets provide more uniform results. After 6 to 9 days of exposure of whole human islets and purified beta cells to IL1b + IFN-g or IL-1b + IFN-g + TNF-a there is induction of functional inhibition [91, 101, 102] , DNA strand breaks [103, 104] and cell death by apoptosis, with a negligible necrotic component [93, 96, 104] . Prevalence of apoptosis in beta cells exposed for 9 days to different concentrations of IL-1b and IFN-g. Cell viability was determined with the DNA binding reagents HO 342 and PI and the apoptotic index calculated as described previously [94] . Apoptosis values in control beta cells were 6. The induction of functional inhibition, DNA strandbreaks and apoptosis is independent of nitric oxide generation, since they cannot be prevented by iNOS blockers [96, 102±104] . Both human and rodent islets produce similar amounts of nitric oxide after exposure to cytokines but while the radical contributes to rat and mouse-islet cell death (see above), it seems less relevant for the demise of human beta cell. This difference between species has been discussed in detail elsewhere [7] and is probably due to the better capacity of human islets to scavenge oxygen free radicals [105] and to the higher content of heat shock protein 70 (hsp70) in these cells [105, 106] . Hsp70 has a direct anti-apoptotic role, by inhibiting protein aggregation, decreasing formation of oxygen free radicals and blocking effector caspases and it could also decrease necrosis by preventing cellular ATP depletion [107] .
The experiments described above indicate that cytokines can directly induce beta-cell death. Two other possible mechanisms by which cytokines could contribute to beta-cell apoptosis in early Type I diabetes is by the up-regulation of Fas [7] and interaction with molecules generated during viral infections. Viral infections probably contribute to the pathogenesis of Type I diabetes [108] . Enteroviruses infect human beta cells in culture, inducing dysfunction and death [108, 109] . A common pathway for viral-induced cellular response in eukaryotic cells is through the cytosolic accumulation of double-stranded RNA (dsRNA; [110] . DsRNA, tested in the form of synthetic polyinosinic-polycytidylic acid, inhibits (pro)insulin biosynthesis in mouse islets [111] and with IL-1b and/or IFN-g, leads to beta-cell death [97, 112] mostly by apoptosis [97] . While IL1b + dsRNA-induced apoptosis is nitric oxide-dependent, IFN-g + dsRNA leads to beta-cell death by a nitric oxide-independent mechanism [97] . The nature of this ªnitric oxide-independent pathwayº remains to be determined. In other cell types, dsRNA signals, at least in part, via activation of a double-stranded (ds) RNA-dependent protein kinase receptor (PKR). PKR was recently shown to be present and up-regulated by IL-1b in pancreatic beta cells [113] . Recent data suggest that islets isolated from mice with catalytically inactive PKR (PKR±/±) are protected against islet cell apoptosis but not against nitric-oxide mediated islet cell dysfunction and necrosis [114, 115] . PKR could degrade IkB and activate nuclear factor-kB (NF-kB) by a specific binding of PKR to the IkB kinase (IKK) beta subunit of the IKK complex, independent of PKR catalytic activity [116, 117] . Further studies are required to determine the exact role of PKR in the process of dsRNA + IL-1b or dsRNA + IFN-g induced beta-cell death by both apoptosis and necrosis. These observations indicate that viral products, in synergism with local cytokine production, could contribute to beta-cell apoptosis in early Type I diabetes.
In summary, there is now a consensus that cytokines are direct mediators of beta-cell death. This occurs by both apoptosis and necrosis, with apoptosis as the predominant form of cytokine-induced beta-cell death in human islets. The radical nitric oxide, produced by islet cells exposed to cytokines, has as more relevant role for the necrotic than for the apoptotic component.
The steps mediating cytokine signalling to the beta cells include: (1) cytokine binding and activation of specific receptors; (2) signal transduction mediated by cytosolic kinases and/or phosphatases; (3) mobilization of diverse transcription factors, such as NFkB and STAT-1 which are kept inactive in the cytosol, or de novo synthesis of transcription factors, such as interferon regulatory factor 1 (IRF-1) and AP-1; (4) import of the activated or newly transcribed transcription factors into the nucleus, where they bind specific sites at the promoter region of responsive genes, up-or down-regulating gene transcription; (5) mRNA export to the cytosol, followed by translation into proteins. In some cases, cytokines exert their actions via phosphorylation and/or dephosphorylation of pre-existing proteins (steps 1 and 2), directly modifying their functions and by-passing steps 3 to 5.
Cytokine receptors and signalling mechanisms in pancreatic beta cells. The IL-1 protein family consists of the two agonists IL-1a and IL-1b and the IL-1 receptor antagonist (IL-1Ra). The two agonists signal via the same receptor [118] , whereas IL-1Ra does not induce signal transduction. There are two IL-1 receptors: IL-1 receptor type 1 and 2 (IL-1R1/2) and beta cells express both IL-1R1 and IL-1R2 [118] . The low affinity IL-1R1 is the signal-transducing receptor, whereas the high affinity IL-1R2 is a decoy receptor [118] . Upon binding of IL-1 to IL-1R1 conformational changes allow docking of an IL-1 receptor accessory protein (IL-1AcP) to the IL-1R1/IL-1 complex (Fig. 2) and binding of IL-1RAcP is crucial for IL-1 signalling. IL-1-induced signal transduction involves three major pathways, i. e. the activation of: nuclear factor kB (NFkB); mitogen-activated protein kinases (MAPK); and protein kinase C (PKC). The IL-1R1 cytoplasmic domain contains putative GTPase activity and hydrolysis of GTP occurs very early after IL-1 R1 activation. Upon IL-1 binding the IL-1RI activated kinase (IRAK) is recruited to the IL-1/IL-1R1/ IL-1AcP complex by the adaptor protein MyD88, which is expressed in beta cells [119] . IRAK recruitment is essential for IL-1 induced signalling and it interacts with the TNF-receptor-associated factor-6 (TRAF6), which has been implicated in NF-kB activation via the NF-kB inducing kinase (NIK). Nuclear factor-kB inducing kinase activates the inhibitory kB (IkB) kinase (IKK) causing phosphorylation and degradation of IkB and the release of NFkB, which then translocates to the nucleus and induces gene transcription [120] . Phosphatidylinositol-3 kinase (PI3K) is also strongly activated and recruited to the IL-1 R1 after IL-1 binding [121] and inhibition of PI3K abrogates IL-1 induced signalling via NFkB and the activating transcription factor 1 (AP-1). PI3K could also regulate PKC and protein kinase B (PKB/Akt) activity [122] .
Interferon-g (IFNg) signals via the IFNg receptor 1 (IFNgR1), which dimerizes and subsequently recruits two identical membrane associated accessory factor proteins (IFNg receptor 2, IFNgR2) (Fig. 2 ).
IFNgR1 and IFNgR2 are associated with the socalled Janus tyrosine kinases 1 and 2 (JAK1/2). When IFNgR1 and 2 are brought together, JAK1 and 2 are activated by auto-phosphorylation and transphosphorylation. Phosphorylation of the IFNgR allows docking of two signal transducers and activators of transcription 1 molecules (STAT1). After docking, STAT1 is activated through phosphorylation by JAK2. STAT1 then homodimerizes and translocates to the nucleus where it binds to gamma-activated sites in the regulatory regions of more than a hundred different genes [123] . STAT1 also activates the transcription factor IRF-1 and IRF-1 binds to interferon-stimulated response elements in many genes. STAT1 regulates caspase expression and thereby cellular response to pro-apoptotic stimuli [124] . The JAKS can also activate the extracellular signal-regulated kinase (ERK) MAPK, PI3 K and phospholipase A 2 accounting for cross-talk with the IL-1 receptor signalling pathway [125] .
The TNF 18-member superfamily, including lymphotoxin (TNFb), FasL and TRAIL [126] signals through the p60 and p80 TNF receptors. The p60 receptors are expressed ubiquitously, whereas expression of the p80 receptor is primarily found on immune and endothelial cells. The p60 and p80 recep- kinase-dependent PKB activation and via phospholipase C and diacylglycerol dependent PKC activation. NFkB is the main transcription factor for iNOS gene expression and probably for the expression of other key genes, still to be identified. AP-1 could be the prime transcriptional factor leading to MAPK dependent apoptosis. MAPKs provide cross-talk links between the signalling pathways of the three cytokines, allowing explanations for the observed synergistic activities of these cytokines on pancreatic beta-cell function and viability tors have similar extracellular but different intracellular domains. The p80 receptor lacks the so-called death domain found on the p60 receptor cytosolic portion, which is considered crucial for transmitting the death signal. The p60 receptor undergoes conformational change after ligand binding and then trimerizes. The death domain of the activated receptor cytoplasmic portion interacts with the TNF receptor associated death domain (TRADD), which in turn recruits the Fas-associated death domain (FADD) (Fig. 2) . TRAF2 and the receptor interacting protein then binds to the p60/TRADD/FADD complex [127] . Following these immediate early events, phospholipases and sphingomyelinases are activated leading to generation of arachidonic acid and diacylglycerol as well as ceramide. Further, protein kinases such as NIK, PKC, c-jun N-terminal kinase (JNK), p38 and PKR are involved in TNF induced signalling [127] . Apoptosis mainly results from MAPK activation of caspase 3 or FADD mediated activation of caspase-8, in turn triggering the final effector caspases [126] .
IL-1 and TNF signalling converges on the NIKNFkB and MAPK pathways, whereas IFN signals mainly via the JAK/STAT pathway, which has crosstalk with the MAPK kinase cascade. The following section concentrates on the role of cytokine-mediated stress-activated and mitogen-activated protein kinases in beta-cell apoptosis.
Mitogen-activated and stress-activated protein kinases. Cellular decision-making on whether extracellular stimuli result in cell division, differentiation or death depends on the co-operation of many signal transduction pathways of which the mitogen-activated and stress-activated protein kinases are important regulators. The dominant members of the MAPK family are the ERK, which is mainly activated by mitogens but also by cellular stressors, and the stress-activated protein kinases p38 and JNK, which are activated by cytokines, changes in extracellular osmolarity or irradiation. All three MAPK's are activated by threonine and/or tyrosine phosphorylation by upstream kinases (Fig. 3) . The active MAPKs in turn phosphorylate serine and threonine residues in substrate proteins including downstream protein kinases and transcription factors. The MAPK pathways are true cascades that enable amplification but also constitute distinct cellular check-points that provide specificity of the intracellular signal in response to pleiotropic stimuli at each level (Fig. 3) [128] . The signalling gateways from the interleukin-1 receptor complex occur mainly at the IRAK tyrosine kinase activation of Ras and Rho as well as TRAF-6, whereas the TNF gateway is mainly TRAF-2 (Fig. 2) . IFN-g signalling cross-talks with the MAPK cascade by JAK activation of Raf [128, 129] .
Recent evidence strongly suggests that MAPKs are crucial signalling elements in cytokine-mediated effects in beta cells. It seems that the MAPK response is differentiated into cytokine-mediated nitric oxide-dependent and independent events. MAPK signalling of cytokine-mediated nitric oxide dependent events. Cytokine-activation of the iNOS gene promoter in beta cells is mainly dependent upon binding of the transcription factor NFkB. p38 MAPK could activate NF-kB and also potentiate NF-kB binding via activation of the transcription factors activating transcription factor 2 (ATF-2) and AP-1 [130] . We therefore investigated if cytokines activate the p38 and ERK signalling pathways in pancreatic islets. IL-1b stimulated ERK-1/2 and p38/ MAPK in both isolated pancreatic rat islets and in RIN cells within minutes and this response was surprisingly sustained for up to 6 to 12 h [131] . Combined inhibition of the p38 and ERK pathways completely blocked IL-1-induced iNOS expression and nitric oxide synthesis but only partially prevented IL-1 induced inhibition of islet insulin release [131] . A non-cytokine stimulus of MAPK pathways by hyperosmolarity did not, however, result in nitric oxide production suggesting that p38 and ERK are necessary but not sufficient for IL-1 induced iNOS expression. Further, TNFa and IFNg, known to potentiate most IL-induced beta-cell effects also potentiated IL-1 beta-stimulated beta-cell MAPK activity [132] . These data suggest that the ERK and p38 pathways are important regulators of cytokine-mediated betacell nitric oxide production. Fig. 3 . Schematic representation of stress-activated and mitogen-activated protein kinase pathways. Mitogens and cellular stresses operate via different but also partially overlapping early signalling events. This involves Ras as the main early activator of the classic mitogen-activated protein kinase pathway, while TRAF2/6 and Rho are early activators of the stress-activated pathway. Ras activation leads to signalling via Raf/ MEK/ERK, whereas both distinct and overlapping MAPK kinase kinase, MAPK kinase and MAPK operate in the stressactivated kinase cascade. MEK, MAPK/ERK kinase MAPK signalling of nitric oxide independent events. To investigate the role of the p38 and ERK pathways in cytokine-induced beta-cell apoptosis, we studied the effect of inhibitors of these pathways on IL-1 + IFN-g-induced apoptosis in primary FACS purified beta cells [133] . Although the inhibitors reduced cytokine-induced beta-cell nitric oxide production, the p38 inhibitor failed to prevent apoptosis, whereas the ERK inhibitor moderately reduced cytokine-induced apoptosis.
Apart from activating the ERK and p38 pathway, IL-1 also activates the JNK pathway [131, 134±136] . Taking advantage of the inhibitory properties of the JNK scaffold protein islet brain 1 (IB-1) or the JNK binding domain (JBD) of this protein, it was possible to show either by overexpressing IB-1 or JBD, or by using cell permeable JBD fused to the HIV Tat protein, that JNK inhibition prevents IL-1 induced apoptosis in several transformed beta-cell lines without blocking nitric oxide production [135, 137] . Of interest, IL-1 reduced beta-cell IB-1 expression [136] increasing the susceptibility of the beta cells to JNK proapoptotic signalling.
These data indicate that MAPKs are central for the signalling of nitric oxide-dependent and nitric oxide-independent effects of cytokines in beta cells. The ERK/p38 pathways are necessary but not sufficient for iNOS expression, whereas the JNK pathway is important for apoptosis induction, at least in transformed beta cells. The protective effect of JNK inhibition against cytokine-induced apoptosis should be tested in primary beta cells, which could have very different MAPK requirements than rapidly dividing and de-differentiated cells.
The MAPK pathways could also provide signalling links to other cytokine-mediated events in pancreatic beta cells. Thus, the p38 MAPK was found to be responsible for signalling of glucose-mediated potentiation of IL-1 induced nitric oxide production and inhibition of insulin release [138] . Cytokine-induced nitric oxide production could be involved in a positive feedback of the MAPK signal [139] providing an explanation for the protracted MAPK activation in cytokine-exposed beta cells [131] and a potential signalling mechanism for nitric oxide induced apoptosis. Since a sustained increase in the cytosolic free calcium concentration has been associated with cytokineinduced apoptosis, and inhibition of high voltage dependent calcium channels protects against cytokineinduced beta-cell apoptosis [140] , it is of interest that inhibition of voltage dependent calcium channels reduced IL-1-stimulated JNK and p38 activity [141] .
Activation of cytosolic MAPKs modifies the activity/expression of transcription factors, leading to changes in nuclear gene transcription (Fig. 3) .
Transcription factors, gene patterns and beta-cell death. The induction of significant beta-cell apoptosis after exposure of purified human, mouse or rat cells to cytokines requires 3 to 9 days [95, 104, 133] . This suggests that de novo gene expression is required for cytokine-induced beta-cell death. Years of research aiming to identify the gene(s) responsible for this process, using the ªcandidate gene approachº and differential display by reverse transcription-polymerase chain reaction, failed to provide a unifying explanation for the phenomenon [7] . This suggests the possibility that apoptosis in primary beta cells ± a complex biological phenomenon ± is not induced by modifications in the expression of one or two genes, but is instead caused by parallel and/or sequential modifications in a large number of genes [7] . At present it is possible to evaluate complex patterns of gene or protein expression by high-density microarrays or proteomics respectively [142±144]. High-density oligonucleotide arrays have already been utilized to determine IL-1b or IL-1b + IFN-g-induced gene expression in primary rat beta cells [145, 146] and IL-1-induced gene expression in transformed RINm5F cells [147] . Proteomic analysis has been done on neonatal rat islets exposed to IL-1b alone [148, 149] , allowing the identification of many interesting proteins regulated by IL-1b [149] or changed as a consequence of IL-1b-induced nitric oxide formation [148] . Proteomics represent an important supplement to gene arrays since gene transcription does not inevitably result in translation and because proteomics also detect posttranslatory protein modifications.
An overview on cytokine-induced changes in primary beta-cell gene expression with potential relevance for cell death is given in Table 5 (based on a microarray analysis in primary beta-cells) [146] . If we accept the concept that beta-cell apoptosis is caused by massive changes in gene expression, we should then look beyond individual genes and focus instead on the transcription factors that regulate ªgene modulesº involved in beta-cell apoptosis (Fig. 4) . From the transcription factors depicted in Figure 4 , two have a high probability of regulating groups of genes contributing to beta-cell death: NF-kB and STAT-1, mediating the signal transduction of IL-1b and IFN-g respectively.
Under basal conditions, NF-kB remains inactive in the cytoplasm, bound to the inhibitory molecule IkB. Following stimuli by cytokines, viral or bacterial products, IkB is phosphorylated and degraded in the proteasome, freeing NF-kB for nuclear translocation [120] . In the nucleus NF-kB modifies the transcription of genes containing NF-kB-binding sites in their promoter regions [150] and several of these genes have a key role in inflammation and could affect the process of cell death [151, 152] . Beta-cell exposure to IL-1b also causes NF-kB translocation to the nucleus [153] , and studies using transient transfections with promoter-luciferase constructs have shown that NF-kB is required for IL-1b-induced expression of mRNAs for iNOS [154] , Mn superoxide dismutase (MnSOD) [155] and Fas [156] . This, and the observation that nearly 20 genes induced by cytokines in beta cells ± several of them with putative pro-apoptotic role ± are potentially NF-kB-regulated [146] , suggest a role for the transcription factor in the process of beta-cell death. This hypothesis was tested by infecting purified rat beta cells with a recombinant adenovirus containing a non-degradable mutant form of IkB, which prevents NF-kB nuclear translocation in these cells. This NF-kB blocker prevented cytokineinduced iNOS and Fas expression and significantly improved beta-cell survival, mostly through the inhibition of apoptosis [157] . Similar results were obtained in whole human islets, where blocking of NFkB activation decreased IL-1b-induced caspase 3 activity, used in the study as an indicator of apoptosis [158] . However, the authors did not characterize the nature of the islet cells undergoing apoptosis and it is not clear whether they are indeed beta cells. Moreover, it is surprising that they observed human-islet cell death with IL-1b alone [158] ± most studies, using well characterized human islet preparations, have shown that these cells are only killed by combinations of 2±3 cytokines [96, 103, 104] . In line with the observations suggesting a pro-apoptotic role for NF-kB, expression of a dominant negative inhibitor of NFkB in insulin-producing MIN6 cells provides a partial protection against IL-1b + IFNg + TNFa-induced apoptosis [159] . Of note, NF-kB also regulates expression of genes which probably oppose beta-cell death, namely MnSOD [155] , A20 [160] and IkBa (which could act as a negative feedback for the NFkB activation) [146] . Cytokine-exposed beta cells express several other genes with putative roles in repair of DNA and defence against cellular stress (Table 5) but it is not clear if these genes are also activated by NF-kB. As suggested by the blocking experiments, the predominant effect of NF-kB-dependent genes is to contribute to beta-cell apoptosis. The nature of these NF-kB-controlled pro-apoptotic genes has yet to be determined but probably Fas, iNOS and c-myc contribute to cell death (Table 5 , Fig. 4 ). These are certainly not the only genes involved, since firstly, Fas up-regulation cannot explain the observed in vitro cytokine-induced cell death, because no Fas ligand is present in the culture medium and rat beta cells do not express this ligand; and secondly, beta cells isolated from iNOS±/± mice die by apoptosis after exposure to cytokines. At present we are doing a new microarray analysis of beta cells exposed to cytokines with or without the concomitant presence of the non-degradable mutant form of IkB. Hopefully, these experiments will show the NF-kB-regulated ªgene modulesº involved in beta-cell death.
As discussed above, IL-1b alone does not induce death in purified human, rat or mouse beta cells. However, when IL-1b is combined with IFN-g, with or without the presence of TNF-a, a large proportion of these cells undergo apoptosis [94±96, 104, 133] . This indicates that the signal transduction mediated by IFN-g is required for beta-cell apoptosis. IFN-g binds to cell surface receptors and activate the tyrosine kinases JAK1 and JAK2 [161] . IL-1b up-regulates JAK2 expression in beta cells [146] , probably potentiating IFN-g signalling. These kinases phosphorylate STAT1, which migrates to the nucleus and binds to g-activated sites of diverse genes [161] . One of the genes activated by STAT1 is interferon-regulatory factor-1 (IRF-1), a transcription factor which regulates several IFN-g-dependent genes. IRF-1 is involved in iNOS regulation in macrophages [162] Gene expression was modified by IL-1b and/or IFN-g after an exposure period of 6±24 h (preceding actual beta-cell apoptosis, which is detectable after 3±6 days). References and discussion on most individual genes is provided in [146] and [7] . SOCS and A20 are described in [160, 179] . i increased; D, decreased; ANT, adenine nucleotide translocator; GADD, growth arrest and DNA damage inducible; MGMT, O-6 methylguanine-DNA methyltransferase; SOCS, suppressor of cytokine signalling; CHOP, CIEBP homologous protein and in triggering apoptosis in T lymphocytes [163] . Thus, IRF-1 seemed to be a logical mediator for the contribution of IFN-g to beta-cell death. This hypothesis was proven incorrect, when it was shown that beta cells obtained from IRF-1±/± mice are as susceptible to cytokine-induced apoptosis as beta cells obtained from wt mice [94] . Islets isolated from IRF-1±/± and allografted into wt mice are more susceptible to destruction than islets isolated from wt mice, suggesting that this transcription factor could actually regulate putative ªprotectiveº genes [81] . If we exclude IRF-1, the main alternative candidate is STAT1. STAT1 activation is the main mediator of IFN-g effects on iNOS expression in insulin producing cells [154] and expression of this transcription factor, together with IRF-1, is up-regulated in islet cells from diabetes-prone NOD mice [164] . Moreover, STAT-1 is critical for ischaemia-induced apoptosis in cardiomyocytes [124] but whether this transcription factor has a similar role in beta-cell apoptosis is not known.
Besides leading to beta-cell apoptosis via NF-kB and STAT1 activation, cytokines could also affect beta-cell survival by decreasing its capacity to metabolize glucose and produce ATP; decreasing cAMP formation; and affecting the handling of Ca2 + (genes potentially related to these three effects are described in Table 5 and in [146] ). At least under in vitro conditions cAMP formation is required for betacell viability [165] and a decrease in GLP-1 and gastric inhibitory peptide (GIP) receptors induced by cytokines [146] will probably contribute to reduced intracellular cAMP content in vivo. A decrease in ATP, mediated by direct inhibitory effects of nitric oxide on beta-cell mitochondria [166] and by decreased expression of GLUT2 and glucokinase [146] could contribute to beta-cell necrosis [7] . These phenomena are probably part of a general process of cytokine-induced beta-cell ªde-differentiationº, with impairment of some of the most differentiated functions of beta cells, such as the preferential mitochondrial metabolism of glucose and the (bio)synthesis and release of insulin [167, 168] . This is paralleled by the activation of proteins related to cell survival, such as heat shock proteins and antioxidant enzymes [146, 153] . This ªde-differentiationº is probably associated to cytokine-induced up-regulation of the transcription factor c-myc [146] and down-regulation of PDX-1 [169] and Isl-1 [146] (Fig. 4) . Increased c-myc expression has been associated with beta-cell growth, de-differentiation and apoptosis, after partial pancreatectomy [170] and during transgenic c-myc expression in beta cells [171] . Since beta-cell growth is directly inhibited by cytokines [168] , probably from a decreased expression of growth hormone and prolactin receptors and of cyclins [146] , the pro-apoptotic effect of c-myc will preponderate. PDX-1 is a crucial gene for beta-cell development and for the maintenance of its differentiated phenotype [172] . The decreased expression of PDX-1, together with the inhibition of Isl-1 expression, could contribute to the observed decreased expression of insulin, GLUT2 and glucokinase mRNAs. While IL-1b alone induces inhibition of PDX-1 and Isl-1 and up-regulation of c-myc, leading to severe inhibition of beta-cell function, it does not trigger beta-cell apoptosis (apoptosis is only present when IL-1b is combined with other cytokines). This suggests that beta-cell ªde-differentiationº, by itself, is not sufficient to cause apoptosis but it could synergise with the signal-transduction of NF-kB, AP-1 and STAT-1 to trigger beta-cell death. In this context, it is conceivable that the special characteristics of beta cells ± its low proliferative capacity, high dependence on mitochondrial function and low capacity to scavenge oxygen free radicals ± makes them especially sensitive to dead signals. While beta cell maturation increases its sensitivity to cytokinemediated cell death [135, 173] , IL-1b-induced betacell ªde-differentiationº (together with induction of hsp70 and free radical scavengers) decreases its susceptibility to necrosis induced by alloxan or streptozotocin [169] .
In a microarray analysis carried out at the early stages of the apoptotic process (after 6 or 24 h of cytokine exposure), we did not observe changes of several ªclassicº pro-apoptotic and anti-apoptotic transcripts, such as Bcl-2, Bcl-x and Bad in primary beta cells [146] . Previous observations that cytokines inhibit Bcl-2 expression in both rat beta cells [174] and human islets [175] were obtained at later periods, and could be a consequence rather than the cause of apoptosis. We suggest that transcriptional regulation of genes from the Bcl-2 family is not the main cause of cytokine-induced beta-cell death. Beta-cell apoptosis depends instead on the parallel and/or sequential up-regulation and down-regulation of a large number of genes combined with modifications on protein translation and activation [146] . A more detailed characterization of the gene groups regulated by NF-kB, AP-1, STAT1 and the additional transcription factors described in Figure 4 might allow us to understand why beta cells eventually decide to start the process of apoptosis. This knowledge will open the door for ªtargetedº approaches to preserve beta-cell life and function in the pre-diabetic period.
Models for immune-mediated nitric oxide dependent and independent beta-cell apoptotic pathways
Based on the evidence reviewed above, we would like to propose two main effector pathways by which the beta cells succumb to cytokine-mediated destruction. The first (Fig. 5) is a pathway dependent upon nitric oxide and therefore, for the reasons discussed above, probably mainly involved in cytokine-mediated rodent beta-cell destruction. In this model, nitric oxide mediated inhibition of aconitase (causing reduction in ATP generation) and DNA strand-breaks (causing activation of poly(ADP)ribose polymerase and NAD + depletion), leads to beta-cell necrosis. Nitric oxide-mediated signalling via guanylcyclase and PKG or via potentiation of MAPK, could lead to activation of c-fos, an important transcription factor in apoptosis induction [176, 177] .
A simplified model for nitric oxide independent beta-cell destruction pathways is suggested (Fig. 6) . The scheme implies that converging signalling from the IFNg, IL-1 and TNFa receptors towards MAPK activation, combined with IL-1 mediated activation of caspase-1 (interleukin-1 converting enzyme, ICE) and other genes still to be determined, leads to effector caspase activation and apoptosis. Similarly, TNF signalling via the FADD/MORT pathway could activate caspase-8, also resulting in apoptosis. It is likely that mitochondrial permeability transition pores are activated probably by the FADD/MORT pathway, leading to the release of cytochrome c, and activation of caspase-9. This is followed by the liberation of calcium, a reduction in ATP generation and GSH as well as a generation of reactive oxygen species. Calcium could further participate in the apoptotic response, whereas the latter factors mainly contribute to necrosis. Some of these steps are blocked by the anti-apoptotic protein Bcl-2 [99, 178] .
Future directions for research in the field
The understanding of the process of beta-cell apoptosis has gained a major impulse in recent years. However, as delineated in this review, our understanding is still fragmentary. Most of the available knowledge on the processes of apoptosis was gained in tumoural cells and it is conceivable that some of the mechanisms leading to cell death in fast dividing cells are of marginal relevance for primary and poorly dividing beta-cells. Several issues deserve further investigation. Among them: (i) The role of Ca2 + and of the factors regulating cytosolic and endoplasmic reticulum Ca2
+ concentration on beta-cell apoptosis and The role of different members of the Bcl-2 family and of mitochondria for beta-cell death; (vii) A clearer understanding of the observed differences between cytokine-induced human and rodent beta-cell death ± which will require the development of better techniques for reliable purification of human beta cells; and (viii) additional microarray and proteomic studies of the gene and protein ªmodulesº participating in beta-cell apoptosis.
In ªA Choice of Murderº [180] , Peter Vansittart describes the life of Timoleon, the leading citizen of Syracuse in late 4th century B. C. Forced to select between submission to one of the ascending empires of the period ± Macedonia, Parthia or Persia ± he choose instead to remain faithful to the end to the Greek ideal of a free City State. In this case, ªThe Choice of Deathº provided an accurate picture of the deceased. It could be that unveiling the process of beta-cell death in Type I diabetes will allow not only a clearer understanding of the pathogenesis of the disease, but will also provide important insights into the basic characteristics of a beta cell. Indeed, we believe that the highly differentiated and sophisticated beta cell dies by apoptosis in early Type I diabetes at least in part because it is a highly differentiated and sophisticated cell.
Note added in proof: Recent evidence suggests that nitric oxide contributes to apoptosis in insulin-producing MIN6 cells by activating the endoplasmic reticulum stress pathway and increasing expression of GADD 153/CHOP [181] . Expression of GADD 153/ CHOP is up-regulated by IL-1b + IFN-g in primary beta cells [146] , and this effect is prevented by iNOS inhibitors (Cardozo and Eizirik, unpublished data). 
